Cleveland Area Dentist Joins Landmark Study

(Newswire.net — August 23, 2019) — Walter Below DMD offers complimentary screenings to patients to research a new surgical prep protocol that could help prevent dental implant loss up to ten-years after implant placement.

500,000 people now have at least one dental implant and may not know their jaw harbors a bacterial infection waiting to explode.  Could Peri-Implantitis be a dental implant time bomb?

“That’s why top tier dentists and medical providers, like Dr. Below, are researching a new surgical prep to stop future bone and implant tooth loss,” cites Leona Meditz, founder of HCP Wellnet, a network of health care professionals sponsoring the protocol.

Periodontal disease causes tooth loss by attacking the bone holding the tooth in place. Peri-implantitis is periodontal disease bacteria that attacks the bone surrounding the implanted tooth causing implant loss.  A ten-year study published in the National Institute of Health found that “The incidence of peri-implantitis was 28.6% in patients with a history of periodontitis, and 5.8% in those patients without a history of the disease”.

Meditz reasoned that if both Periodontal disease and Peri-Implantitis share the same bone destroying bacteria, then reducing that bacteria in the mouth before and after surgery should greatly reduce dental implant loss.  Her protocol includes Laser Assisted Periodontal Therapy, Scaling and Root Planing and Clean Kiss Organic Oral Care Products with anti-inflammatory and bone support supplements.  The 30 Second Smile™ toothbrush and Hydrofloss™ oral irrigator are also used.

Dr. Walter Below, practicing in the Cleveland area since 1982, agrees with her hypothesis and has been using this new protocol with great success.  “This research will scientifically prove my practice findings” he states.  Dr. Below is offering complimentary screenings to qualify patients for the study that include A1c and Crp testing to determine how much periodontal bacteria increases health risks for heart disease and diabetes, among other inflammatory diseases. Research participants also receive up to $1,000 savings on dental services.

Internationally recognized expert in Molecular Biology and Genetics, Ronald C. McGlennen, M.D. President & Medical Director of OralDNA® Labs LLC and Associate Professor of Pathology at the University of Minnesota Medical School, developed the testing used to scientifically diagnose periodontal disease level pre and post therapy within the study.

Patients wishing to participate should Call 440-871-1155 to set your complementary screening.

###

The names of actual companies and products mentioned herein may be trademarks of their respective owners